Y
600351
vs
S
Shanghai Composite
Over the past 12 months, Yabao Pharmaceutical Group Co Ltd has underperformed Shanghai Composite, delivering a return of +19% compared to the Shanghai Composite's +34% growth.
Stocks Performance
600351 vs Shanghai Composite
Performance Gap
600351 vs Shanghai Composite
Performance By Year
600351 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Yabao Pharmaceutical Group Co Ltd
Glance View
Yabao Pharmaceutical Group Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 4,732 full-time employees. The company went IPO on 2002-09-26. The firm mainly provides light pastes, tablets, injections, capsules, oral liquids, bulk drugs and other pharmaceutical products. The firm is also engaged in the wholesaling and trading of pharmaceuticals. The firm distributes its products within domestic market and to overseas markets.
